MarketLens
Sign Up

Has Abbott Laboratories Just Redefined Its Future with Exact Sciences

6 months ago
SHARE THIS ON:

Has Abbott Laboratories Just Redefined Its Future with Exact Sciences

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News1 months ago

Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant

Abbott Laboratories fell 16% this year to $105.70, versus a Street consensus target of $118.42, implying ~12% upside. One analyst sees 35% gains, citing potential recovery.
Stock News1 months ago

Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends

Abbott is expanding across diabetes care, oncology diagnostics and heart devices via new launches and acquisitions, creating multiple growth paths.
Stock News2 months ago

Abbott Laboratories: Pick Up This Dividend King Deal Now

Abbott Laboratories shares have rallied since May, driven by strength in Medical Devices and the Exact Sciences acquisition. The company maintains an A+ S&P credit rating with stable outlook.

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

Generac, Amazon strike $2.4 billion long-term generator supply deal

Stock News2 hours ago

A Broad-Based Earnings Growth Picture as Revisions Stay Positive

Stock News2 hours ago

Why Intel Stock Jumped Today

Stock News2 hours ago

LARRY KUDLOW: Prosperity is as American as apple pie

Stock News2 hours ago

Diamondback Energy Inc (FANG) Stock Down 8.0% -- Now Undervalued? GF Score: 61/100